These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26427334)

  • 1. A common promoter hypomethylation signature in invasive breast, liver and prostate cancer cell lines reveals novel targets involved in cancer invasiveness.
    Cheishvili D; Stefanska B; Yi C; Li CC; Yu P; Arakelian A; Tanvir I; Khan HA; Rabbani S; Szyf M
    Oncotarget; 2015 Oct; 6(32):33253-68. PubMed ID: 26427334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definition of the landscape of promoter DNA hypomethylation in liver cancer.
    Stefanska B; Huang J; Bhattacharyya B; Suderman M; Hallett M; Han ZG; Szyf M
    Cancer Res; 2011 Sep; 71(17):5891-903. PubMed ID: 21747116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
    Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y
    Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors.
    Chik F; Szyf M
    Carcinogenesis; 2011 Feb; 32(2):224-32. PubMed ID: 20980350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ITIH5 induces a shift in TGF-β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death.
    Rose M; Meurer SK; Kloten V; Weiskirchen R; Denecke B; Antonopoulos W; Deckert M; Knüchel R; Dahl E
    Mol Carcinog; 2018 Feb; 57(2):167-181. PubMed ID: 28940371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular levels of S-adenosylhomocysteine but not homocysteine are highly correlated to the expression of nm23-H1 and the level of 5-methyldeoxycytidine in human hepatoma cells with different invasion activities.
    Yang TH; Hu ML
    Nutr Cancer; 2006; 55(2):224-31. PubMed ID: 17044778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene.
    Lam S; Wiercinska E; Teunisse AF; Lodder K; ten Dijke P; Jochemsen AG
    Breast Cancer Res Treat; 2014 Nov; 148(1):7-18. PubMed ID: 25257729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo.
    Shukeir N; Pakneshan P; Chen G; Szyf M; Rabbani SA
    Cancer Res; 2006 Sep; 66(18):9202-10. PubMed ID: 16982764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Promoter methylation and mRNA expression of APC gene in MCF10 breast cancer model].
    Yang JL; Klinkebiel D; Boland MJ; Tang L; Christman JK
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):32-6. PubMed ID: 16608647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological methyl group donors block skeletal metastasis in vitro and in vivo.
    Shukeir N; Stefanska B; Parashar S; Chik F; Arakelian A; Szyf M; Rabbani SA
    Br J Pharmacol; 2015 Jun; 172(11):2769-81. PubMed ID: 25631332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
    Huanna T; Tao Z; Xiangfei W; Longfei A; Yuanyuan X; Jianhua W; Cuifang Z; Manjing J; Wenjing C; Shaochuan Q; Feifei X; Naikang L; Jinchao Z; Chen W
    Mol Carcinog; 2015 Oct; 54(10):1159-71. PubMed ID: 24962947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo.
    Pakneshan P; Xing RH; Rabbani SA
    FASEB J; 2003 Jun; 17(9):1081-8. PubMed ID: 12773490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.
    Paredes J; Albergaria A; Oliveira JT; Jerónimo C; Milanezi F; Schmitt FC
    Clin Cancer Res; 2005 Aug; 11(16):5869-77. PubMed ID: 16115928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells.
    Pakneshan P; Szyf M; Rabbani SA
    Carcinogenesis; 2005 Mar; 26(3):557-64. PubMed ID: 15618232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of N-myc downstream regulated gene 1 caused by the methylation of CpG islands of NDRG1 promoter promotes proliferation and invasion of prostate cancer cells.
    Li Y; Pan P; Qiao P; Liu R
    Int J Oncol; 2015 Sep; 47(3):1001-8. PubMed ID: 26202882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide study of hypomethylated and induced genes in patients with liver cancer unravels novel anticancer targets.
    Stefanska B; Cheishvili D; Suderman M; Arakelian A; Huang J; Hallett M; Han ZG; Al-Mahtab M; Akbar SM; Khan WA; Raqib R; Tanvir I; Khan HA; Rabbani SA; Szyf M
    Clin Cancer Res; 2014 Jun; 20(12):3118-32. PubMed ID: 24763612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNMT1 silencing affects locus specific DNA methylation and increases prostate cancer derived PC3 cell invasiveness.
    Yaqinuddin A; Qureshi SA; Qazi R; Farooq S; Abbas F
    J Urol; 2009 Aug; 182(2):756-61. PubMed ID: 19539327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.